|
US20030121063A1
(en)
|
1995-11-16 |
2003-06-26 |
The Trustees Of The University Of Pennsylvania |
Compositions and methods of use of mammalian retrotransposons
|
|
US6693086B1
(en)
|
1998-06-25 |
2004-02-17 |
National Jewish Medical And Research Center |
Systemic immune activation method using nucleic acid-lipid complexes
|
|
US20060183226A1
(en)
|
2002-01-31 |
2006-08-17 |
Haruhiko Fujiwara |
Methods for retrotransposing long interspersed elements (lines)
|
|
US20070037759A1
(en)
|
2003-02-07 |
2007-02-15 |
Administrators Of The Tulane Educational Fund, The |
Mammalian retrotransposable elements
|
|
US20080104723A1
(en)
|
2003-11-21 |
2008-05-01 |
Osaka Industrial Promojtion Organization C/O Mydom |
Development of Mammalian Genome Modification Technique Using Retrotransposon
|
|
WO2007130543A2
(en)
|
2006-05-04 |
2007-11-15 |
Abmaxis Inc. |
Method for producing stable mammalian cell lines producing high levels of recombinant proteins
|
|
EP2055784A1
(en)
|
2007-10-31 |
2009-05-06 |
Bundesrepublik Deutschland, letztvertreten durch den Präsidenten des Paul-Ehrlich-Instituts Prof. Dr. Johannes Löwer |
Controlled activation of non-LTR retrotransposons in mammals
|
|
US8889394B2
(en)
|
2009-09-07 |
2014-11-18 |
Empire Technology Development Llc |
Multiple domain proteins
|
|
US20140113375A1
(en)
|
2012-10-21 |
2014-04-24 |
Lixin Liu |
Transient Expression And Reverse Transcription Aided Genome Alteration System
|
|
EP3064585B1
(en)
|
2012-12-12 |
2020-02-05 |
The Broad Institute, Inc. |
Engineering and optimization of improved systems, methods and enzyme compositions for sequence manipulation
|
|
CN105209621B
(zh)
|
2012-12-12 |
2021-05-25 |
布罗德研究所有限公司 |
对用于序列操纵的改进的系统、方法和酶组合物进行的工程化和优化
|
|
ES2749624T3
(es)
|
2013-03-14 |
2020-03-23 |
Caribou Biosciences Inc |
Composiciones y métodos de ácidos nucleicos dirigidos a ácido nucleico
|
|
US20140349400A1
(en)
|
2013-03-15 |
2014-11-27 |
Massachusetts Institute Of Technology |
Programmable Modification of DNA
|
|
US9340799B2
(en)
|
2013-09-06 |
2016-05-17 |
President And Fellows Of Harvard College |
MRNA-sensing switchable gRNAs
|
|
CN111218447B
(zh)
|
2013-11-07 |
2024-10-11 |
爱迪塔斯医药有限公司 |
使用统治型gRNA的CRISPR相关方法和组合物
|
|
WO2015191693A2
(en)
|
2014-06-10 |
2015-12-17 |
Massachusetts Institute Of Technology |
Method for gene editing
|
|
WO2016028843A2
(en)
|
2014-08-19 |
2016-02-25 |
President And Fellows Of Harvard College |
Rna-guided systems for probing and mapping of nucleic acids
|
|
WO2016036754A1
(en)
|
2014-09-02 |
2016-03-10 |
The Regents Of The University Of California |
Methods and compositions for rna-directed target dna modification
|
|
WO2016065364A1
(en)
|
2014-10-24 |
2016-04-28 |
Life Technologies Corporation |
Compositions and methods for enhancing homologous recombination
|
|
US11911415B2
(en)
|
2015-06-09 |
2024-02-27 |
Editas Medicine, Inc. |
CRISPR/Cas-related methods and compositions for improving transplantation
|
|
WO2016205728A1
(en)
|
2015-06-17 |
2016-12-22 |
Massachusetts Institute Of Technology |
Crispr mediated recording of cellular events
|
|
WO2017059241A1
(en)
|
2015-10-02 |
2017-04-06 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Lentiviral protein delivery system for rna-guided genome editing
|
|
WO2017123609A1
(en)
|
2016-01-12 |
2017-07-20 |
The Regents Of The University Of California |
Compositions and methods for enhanced genome editing
|
|
US20170275665A1
(en)
|
2016-02-24 |
2017-09-28 |
Board Of Regents, The University Of Texas System |
Direct crispr spacer acquisition from rna by a reverse-transcriptase-cas1 fusion protein
|
|
US11447768B2
(en)
|
2016-03-01 |
2022-09-20 |
University Of Florida Research Foundation, Incorporated |
Molecular cell diary system
|
|
WO2017173004A1
(en)
|
2016-03-30 |
2017-10-05 |
Mikuni Takayasu |
A method for in vivo precise genome editing
|
|
WO2017180711A1
(en)
|
2016-04-13 |
2017-10-19 |
Editas Medicine, Inc. |
Grna fusion molecules, gene editing systems, and methods of use thereof
|
|
KR102370675B1
(ko)
|
2016-04-29 |
2022-03-04 |
바스프 플랜트 사이언스 컴퍼니 게엠베하 |
표적 핵산의 변형을 위한 개선된 방법
|
|
WO2017197238A1
(en)
|
2016-05-12 |
2017-11-16 |
President And Fellows Of Harvard College |
Aav split cas9 genome editing and transcriptional regulation
|
|
WO2018027078A1
(en)
|
2016-08-03 |
2018-02-08 |
President And Fellows Of Harard College |
Adenosine nucleobase editors and uses thereof
|
|
WO2018045321A1
(en)
|
2016-09-02 |
2018-03-08 |
North Carolina State University |
Methods and compositions for modification of plastid genomes
|
|
EP4431607A3
(en)
|
2016-09-09 |
2024-12-11 |
The Board of Trustees of the Leland Stanford Junior University |
High-throughput precision genome editing
|
|
US20190330620A1
(en)
|
2016-10-14 |
2019-10-31 |
Emendobio Inc. |
Rna compositions for genome editing
|
|
WO2018089860A1
(en)
|
2016-11-11 |
2018-05-17 |
2D Genomics Inc. |
Methods for processing nucleic acid samples
|
|
CN110914310A
(zh)
|
2017-03-10 |
2020-03-24 |
哈佛大学的校长及成员们 |
胞嘧啶至鸟嘌呤碱基编辑器
|
|
IL306092A
(en)
|
2017-03-23 |
2023-11-01 |
Harvard College |
Nucleic base editors that include nucleic acid programmable DNA binding proteins
|
|
CA3063733A1
(en)
|
2017-05-25 |
2018-11-29 |
The General Hospital Corporation |
Base editors with improved precision and specificity
|
|
WO2019051097A1
(en)
|
2017-09-08 |
2019-03-14 |
The Regents Of The University Of California |
RNA-GUIDED ENDONUCLEASE FUSION POLYPEPTIDES AND METHODS OF USING SAME
|
|
JP2021530212A
(ja)
|
2018-07-13 |
2021-11-11 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニアThe Regents Of The University Of California |
レトロトランスポゾンベースの送達媒体及びその使用方法
|
|
AU2019327449B2
(en)
|
2018-08-28 |
2026-04-09 |
Flagship Pioneering Innovations Vi, Llc |
Methods and compositions for modulating a genome
|
|
CN117925571A
(zh)
|
2018-10-19 |
2024-04-26 |
德克萨斯州大学系统董事会 |
工程化长散在元件（line）转座子及其使用方法
|
|
US12410429B2
(en)
|
2019-03-14 |
2025-09-09 |
Cornell University |
Compositions and methods for gene targeting using CRISPR-Cas and transposons
|
|
WO2020191241A1
(en)
|
2019-03-19 |
2020-09-24 |
The Broad Institute, Inc. |
Methods and compositions for editing nucleotide sequences
|
|
US20220298495A1
(en)
|
2019-06-12 |
2022-09-22 |
Emendobio Inc. |
Novel genome editing tool
|
|
CA3147875A1
(en)
|
2019-07-19 |
2021-01-28 |
Flagship Pioneering Innovations Vi, Llc |
Recombinase compositions and methods of use
|
|
EP4034659A4
(en)
|
2019-09-27 |
2024-10-16 |
The Broad Institute, Inc. |
PROGRAMMABLE POLYNUCLEOTIDE EDITORS FOR AMPLIFIED HOMOLOGOUS RECOMBINATION
|
|
WO2021080922A1
(en)
|
2019-10-21 |
2021-04-29 |
The Trustees Of Columbia University In The City Of New York |
Methods of performing rna templated genome editing
|
|
EP4061940A4
(en)
|
2019-11-22 |
2024-10-23 |
Flagship Pioneering Innovations VI, LLC |
RECOMBINASE COMPOSITIONS AND METHODS OF USE
|
|
WO2021138469A1
(en)
|
2019-12-30 |
2021-07-08 |
The Broad Institute, Inc. |
Genome editing using reverse transcriptase enabled and fully active crispr complexes
|
|
IL296095A
(en)
|
2020-03-04 |
2022-11-01 |
Flagship Pioneering Innovations Vi Llc |
Improved methods and compositions for genome modulation
|
|
US20230348939A1
(en)
|
2020-03-04 |
2023-11-02 |
Flagship Pioneering Innovations Vi, Llc |
Methods and compositions for modulating a genome
|
|
BR112022017715A2
(pt)
|
2020-03-04 |
2022-11-16 |
Flagship Pioneering Innovations Vi Llc |
Métodos e composições para modular um genoma
|
|
AU2021232005A1
(en)
|
2020-03-04 |
2022-09-29 |
Flagship Pioneering Innovations Vi, Llc |
Methods and compositions for modulating a genome
|
|
BR112022017735A2
(pt)
|
2020-03-05 |
2022-11-29 |
Flagship Pioneering Innovations Vi Llc |
Métodos e composições de supressão de defesa de hospedeiro para modular um genoma
|
|
CA3177481A1
(en)
|
2020-05-08 |
2021-11-11 |
David R. Liu |
Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence
|
|
WO2021248102A1
(en)
|
2020-06-05 |
2021-12-09 |
Flagship Pioneering Innovations Vi, Llc |
Template guide rna molecules
|
|
AU2022206476A1
(en)
|
2021-01-11 |
2023-07-20 |
President And Fellows Of Harvard College |
Prime editor variants, constructs, and methods for enhancing prime editing efficiency and precision
|
|
US20240132916A1
(en)
|
2021-02-09 |
2024-04-25 |
The Broad Institute, Inc. |
Nuclease-guided non-ltr retrotransposons and uses thereof
|
|
WO2022183210A1
(en)
|
2021-02-26 |
2022-09-01 |
Flagship Pioneering Innovations Vi, Llc |
Tissue-specific methods and compositions for modulating a genome
|
|
AU2022240747A1
(en)
|
2021-03-19 |
2023-10-05 |
Flagship Pioneering Innovations Vi, Llc |
Ltr transposon compositions and methods
|
|
EP4314257A4
(en)
|
2021-04-01 |
2025-07-09 |
Prime Medicine Inc |
METHODS AND COMPOSITIONS FOR EDITING NUCLEOTIDE SEQUENCES
|
|
EP4347859A4
(en)
|
2021-05-26 |
2025-07-02 |
Flagship Pioneering Innovations Vi Llc |
INTEGRASE COMPOSITIONS AND METHODS
|
|
EP4352230A4
(en)
|
2021-06-03 |
2025-06-11 |
Prime Medicine, Inc. |
Genome editing compositions and methods for treating Wilson's disease
|
|
WO2023283092A1
(en)
|
2021-07-06 |
2023-01-12 |
Prime Medicine, Inc. |
Compositions and methods for efficient genome editing
|
|
WO2023004439A2
(en)
|
2021-07-23 |
2023-01-26 |
Prime Medicine, Inc. |
Genome editing compositions and methods for treatment of chronic granulomatous disease
|
|
WO2023015318A2
(en)
|
2021-08-05 |
2023-02-09 |
Prime Medicine, Inc. |
Genome editing compositions and methods for treatment of cystic fibrosis
|
|
KR20260037664A
(ko)
|
2021-09-08 |
2026-03-18 |
플래그쉽 파이어니어링 이노베이션스 브이아이, 엘엘씨 |
게놈을 조절하기 위한 방법 및 조성물
|
|
CA3231712A1
(en)
|
2021-09-08 |
2023-03-16 |
Flagship Pioneering Innovations Vi, Llc |
Pah-modulating compositions and methods
|
|
WO2023039447A2
(en)
|
2021-09-08 |
2023-03-16 |
Flagship Pioneering Innovations Vi, Llc |
Serpina-modulating compositions and methods
|
|
MX2024002930A
(es)
|
2021-09-08 |
2024-05-29 |
Flagship Pioneering Innovations Vi Llc |
Metodos y composiciones para modular un genoma.
|
|
EP4399307A4
(en)
|
2021-09-08 |
2026-01-21 |
Flagship Pioneering Innovations Vi Llc |
HBB COMPOSITIONS AND MODULATION METHODS
|
|
CA3235826A1
(en)
|
2021-10-21 |
2023-04-27 |
Wei Hsi Yeh |
Genome editing compositions and methods for treatment of usher syndrome type 3
|
|
US20250319202A1
(en)
|
2021-11-09 |
2025-10-16 |
Prime Medicine, Inc. |
Genome editing compositions and methods for treatment of fuchs endothelial corneal dystrophy
|
|
US20250011766A1
(en)
|
2021-11-09 |
2025-01-09 |
Prime Medicine, Inc. |
Genome Editing Compositions and Methods for Treatment of Amyotrophic Lateral Sclerosis
|
|
EP4430189A1
(en)
|
2021-11-11 |
2024-09-18 |
Prime Medicine, Inc. |
Genome editing compositions and methods for treatment of fragile x syndrome
|
|
US20250297248A1
(en)
|
2021-11-24 |
2025-09-25 |
Prime Medicine, Inc. |
Methods and compositions for inhibiting mismatch repair
|
|
AU2022398241A1
(en)
|
2021-11-24 |
2024-06-06 |
Prime Medicine, Inc. |
Modified prime editing guide rnas
|
|
EP4444362A4
(en)
|
2021-12-10 |
2026-04-01 |
Flagship Pioneering Innovations Vi Llc |
CFTR COMPOSITIONS AND MODULATION METHODS
|
|
WO2023192655A2
(en)
|
2022-04-01 |
2023-10-05 |
Prime Medicine, Inc. |
Methods and compositions for editing nucleotide sequences
|